$QSG
QuantaSing Group Ltd Stock $qsg

$qsg Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 20-F Financial Statement

#000101376223007052 Filed on October 27, 2023

Income Statement

Concept	2023 Q2	2023	2022 Q2
Revenue	$828.3M	3.081B cnies
YoY Change		7.44%
Cost Of Revenue	$116.1M	$53.99M
YoY Change		-86.79%
Gross Profit	$712.2M	$371.0M
YoY Change		-84.92%
Gross Profit Margin	85.98%	12.04%
Selling, General & Admin	$611.0M	$356.3M
YoY Change		-85.28%
% of Gross Profit	85.79%	96.05%
Research & Development	$53.60M	$30.31M
YoY Change		-88.92%
% of Gross Profit	7.53%	8.17%
Depreciation & Amortization	$2.900M	3.714M cnies	$10.59M
YoY Change	-72.63%	-64.95%
% of Gross Profit	0.41%	1.0%
Operating Expenses	$664.7M	$386.6M
YoY Change		-85.65%
Operating Profit	$47.50M	-$15.67M
YoY Change		-93.34%
Interest Expense	$2.700M	$14.60M
YoY Change		176.46%
% of Operating Profit	5.68%
Other Income/Expense, Net	$6.200M	$2.939M
YoY Change		-80.43%
Pretax Income	$56.40M	-$11.99M
YoY Change		-94.42%
Income Tax	$3.700M	21.69M cnies
% Of Pretax Income	6.56%
Net Earnings	$52.80M	-108.5M cnies
YoY Change		-58.1%
Net Earnings / Revenue	6.37%	-3.52%
Basic Earnings Per Share		-$1.26
Diluted Earnings Per Share	$0.30	-$1.26
COMMON SHARES
Basic Shares Outstanding		103.9M shares
Diluted Shares Outstanding		103.9M shares

Balance Sheet

Concept	2023 Q2	2023	2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$930.6M	$930.6M
YoY Change		133.2%
Cash & Equivalents	$105.4M	$764.3M	266.4M cnies
Short-Term Investments	$166.3M	$166.3M
Other Short-Term Assets		$112.4M	19.00K cnies
YoY Change		5.93%
Inventory
Prepaid Expenses
Receivables	$1.689M	$12.30M	1.937M cnies
Other Receivables	$29.10M	$53.40M
Total Short-Term Assets	$152.9M	$1.109B	564.0M cnies
YoY Change	-72.89%	96.58%
LONG-TERM ASSETS
Property, Plant & Equipment	7.409M cnies	$91.40M	5.169M cnies
YoY Change	43.34%	214.24%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$2.937M	$23.40M	10.43M cnies
YoY Change	-71.84%	124.35%
Total Long-Term Assets	$15.83M	$114.8M	39.52M cnies
YoY Change	-59.94%	190.52%
TOTAL ASSETS
Total Short-Term Assets	$152.9M	$1.109B	564.0M cnies
Total Long-Term Assets	$15.83M	$114.8M	39.52M cnies
Total Assets	$168.7M	$1.223B	603.5M cnies
YoY Change	-72.04%	102.73%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$8.563M	$62.10M	45.18M cnies
YoY Change	-81.05%	37.46%
Accrued Expenses	171.2M cnies	$211.3M	108.6M cnies
YoY Change	57.62%	70.43%
Deferred Revenue	517.2M cnies		384.7M cnies
YoY Change	34.44%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$130.3M	$944.8M	713.2M cnies
YoY Change	-81.73%	32.47%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$52.80M	$52.80M
YoY Change		242.08%
Total Long-Term Liabilities	$7.288M	$52.80M	15.44M cnies
YoY Change	-52.78%	242.08%
TOTAL LIABILITIES
Total Short-Term Liabilities	$130.3M	$944.8M	713.2M cnies
Total Long-Term Liabilities	$7.288M	$52.80M	15.44M cnies
Total Liabilities	$137.6M	$999.7M	728.7M cnies
YoY Change	-81.12%	37.2%
SHAREHOLDERS EQUITY
Retained Earnings	-$133.7M		-861.2M cnies
YoY Change	-84.47%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$30.85M	$223.7M	-789.3M cnies
YoY Change
Total Liabilities & Shareholders Equity	$168.7M	$1.223B	603.5M cnies
YoY Change	-72.04%	102.73%

Cashflow Statement

Concept	2023 Q2	2023	2022 Q2
OPERATING ACTIVITIES
Net Income	$52.80M	-108.5M cnies
YoY Change		-58.1%
Depreciation, Depletion And Amortization	$2.900M	3.714M cnies	$10.59M
YoY Change	-72.63%	-64.95%
Cash From Operating Activities	$207.1M	$32.49M	$272.6M
YoY Change	-24.04%	-88.08%
INVESTING ACTIVITIES
Capital Expenditures	$5.700M	$794.0K	$4.560M
YoY Change	25.0%	-82.59%
Acquisitions
YoY Change
Other Investing Activities	-$147.4M	$6.000M	-$104.0M
YoY Change	41.7%	-105.77%
Cash From Investing Activities	-$153.1M	$28.00K	-$108.6M
YoY Change	41.0%	-100.03%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		15.92M cnies
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	247.7M	$34.16M	71.63M
YoY Change	245.81%	-52.31%
NET CHANGE
Cash From Operating Activities	207.1M	$32.49M	272.6M
Cash From Investing Activities	-153.1M	$28.00K	-108.6M
Cash From Financing Activities	247.7M	$34.16M	71.63M
Net Change In Cash	301.7M	$68.66M	235.7M
YoY Change	28.01%	-70.87%
FREE CASH FLOW
Cash From Operating Activities	$207.1M	$32.49M	$272.6M
Capital Expenditures	$5.700M	$794.0K	$4.560M
Free Cash Flow	$201.4M	$31.70M	$268.1M
YoY Change	-24.87%	-88.18%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Document Type DocumentType	20-F
CY2023	dei	Document Registration Statement DocumentRegistrationStatement	false
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Document Shell Company Report DocumentShellCompanyReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-41590
CY2023	dei	Entity Registrant Name EntityRegistrantName	QuantaSing Group Limited
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	E9
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	2/F, Building D
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Ronsin Technology Center
CY2023	dei	Entity Address Address Line3 EntityAddressAddressLine3	Chaoyang District
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Beijing
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	100102
CY2023	dei	Entity Address Country EntityAddressCountry	CN
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Document Accounting Standard DocumentAccountingStandard	U.S. GAAP
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023	dei	Auditor Firm AuditorFirmId	1424
CY2023	dei	Auditor Name AuditorName	PricewaterhouseCoopers Zhong Tian LLP
CY2023	dei	Auditor Location AuditorLocation	China
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	266427000	cny
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	764281000	cny
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	105399000	usd
CY2022Q2	us-gaap	Short Term Investments ShortTermInvestments	132632000	cny
CY2023Q2	us-gaap	Short Term Investments ShortTermInvestments	166303000	cny
CY2023Q2	us-gaap	Short Term Investments ShortTermInvestments	22934000	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1937000	cny
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	12251000	cny
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1689000	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	115560000	cny
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	136681000	cny
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	18851000	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	563950000	cny
CY2023Q2	us-gaap	Assets Current AssetsCurrent	1108632000	cny
CY2023Q2	us-gaap	Assets Current AssetsCurrent	152888000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5169000	cny
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7409000	cny
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1022000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	23917000	cny
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	84009000	cny
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	11585000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	2084000	cny
CY2023Q2	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	287000	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	10430000	cny
CY2023Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	21296000	cny
CY2023Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2937000	usd
CY2022Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	39516000	cny
CY2023Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	114798000	cny
CY2023Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	15831000	usd
CY2022Q2	us-gaap	Assets Assets	603466000	cny
CY2023Q2	us-gaap	Assets Assets	1223430000	cny
CY2023Q2	us-gaap	Assets Assets	168719000	usd
CY2022Q2	qsg	Primary Beneficiary Accounts Payables PrimaryBeneficiaryAccountsPayables	45178000	cny
CY2023Q2	qsg	Primary Beneficiary Accounts Payables PrimaryBeneficiaryAccountsPayables	62094000	cny
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	45178000	cny
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	62094000	cny
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	8563000	usd
CY2022Q2	qsg	Primary Beneficiary Accrued Expenses PrimaryBeneficiaryAccruedExpenses	77616000	cny
CY2023Q2	qsg	Primary Beneficiary Accrued Expenses PrimaryBeneficiaryAccruedExpenses	124532000	cny
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	108592000	cny
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	171160000	cny
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	23604000	usd
CY2022Q2	qsg	Primary Beneficiary Income Tax Payable PrimaryBeneficiaryIncomeTaxPayable	7298000	cny
CY2023Q2	qsg	Primary Beneficiary Income Tax Payable PrimaryBeneficiaryIncomeTaxPayable	8794000	cny
CY2022Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	7298000	cny
CY2023Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	8794000	cny
CY2023Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	1213000	usd
CY2022Q2	qsg	Primary Beneficiary Contract Liabilities Current Portion PrimaryBeneficiaryContractLiabilitiesCurrentPortion	384729000	cny
CY2023Q2	qsg	Primary Beneficiary Contract Liabilities Current Portion PrimaryBeneficiaryContractLiabilitiesCurrentPortion	517213000	cny
CY2022Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	384729000	cny
CY2023Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	517213000	cny
CY2023Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	71327000	usd
CY2022Q2	qsg	Primary Beneficiary Advance From Customers PrimaryBeneficiaryAdvanceFromCustomers	151089000	cny
CY2023Q2	qsg	Primary Beneficiary Advance From Customers PrimaryBeneficiaryAdvanceFromCustomers	144397000	cny
CY2022Q2	qsg	Advance From Customers AdvanceFromCustomers	151089000	cny
CY2023Q2	qsg	Advance From Customers AdvanceFromCustomers	144397000	cny
CY2023Q2	qsg	Advance From Customers AdvanceFromCustomers	19913000	usd
CY2022Q2	qsg	Primary Beneficiary Operating Lease Liabilities Current Portion PrimaryBeneficiaryOperatingLeaseLiabilitiesCurrentPortion	14875000	cny
CY2023Q2	qsg	Prepayments For Products Procurement PrepaymentsForProductsProcurement	13543000	cny
CY2023Q2	qsg	Primary Beneficiary Operating Lease Liabilities Current Portion PrimaryBeneficiaryOperatingLeaseLiabilitiesCurrentPortion	21425000	cny
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	16331000	cny
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	41092000	cny
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	5667000	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	713217000	cny
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	944750000	cny
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	130287000	usd
CY2022Q2	qsg	Primary Beneficiary Contract Liabilities Noncurrent Portion PrimaryBeneficiaryContractLiabilitiesNoncurrentPortion	8869000	cny
CY2023Q2	qsg	Primary Beneficiary Contract Liabilities Noncurrent Portion PrimaryBeneficiaryContractLiabilitiesNoncurrentPortion	7000	cny
CY2022Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	8869000	cny
CY2023Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	7000	cny
CY2023Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	1000	usd
CY2022Q2	qsg	Primary Beneficiary Operating Lease Liabilities Noncurrent Portion PrimaryBeneficiaryOperatingLeaseLiabilitiesNoncurrentPortion	6522000	cny
CY2023Q2	qsg	Primary Beneficiary Operating Lease Liabilities Noncurrent Portion PrimaryBeneficiaryOperatingLeaseLiabilitiesNoncurrentPortion	23786000	cny
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6566000	cny
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	52840000	cny
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7287000	usd
CY2022Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	15435000	cny
CY2023Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	52847000	cny
CY2023Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	7288000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	728652000	cny
CY2023Q2	us-gaap	Liabilities Liabilities	997597000	cny
CY2023Q2	us-gaap	Liabilities Liabilities	137575000	usd
CY2022Q2	us-gaap	Members Equity Attributable To Noncontrolling Interest MembersEquityAttributableToNoncontrollingInterest	664160000	cny
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	69934000	cny
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1171092000	cny
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	161501000	usd
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1839000	cny
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	22182000	cny
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	3059000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-861151000	cny
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-969688000	cny
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-133726000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-789346000	cny
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	223698000	cny
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	30850000	usd
CY2023Q2	us-gaap	Minority Interest MinorityInterest	2135000	cny
CY2023Q2	us-gaap	Minority Interest MinorityInterest	294000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-789346000	cny
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	225833000	cny
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	31144000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	603466000	cny
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1223430000	cny
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	168719000	usd
CY2021	us-gaap	Revenues Revenues	1759940000	cny
CY2022	us-gaap	Revenues Revenues	2867974000	cny
CY2023	us-gaap	Revenues Revenues	3081381000	cny
CY2023	us-gaap	Revenues Revenues	424942000	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	178927000	cny
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	408757000	cny
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	391498000	cny
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	53990000	usd
CY2021	us-gaap	Gross Profit GrossProfit	1581013000	cny
CY2022	us-gaap	Gross Profit GrossProfit	2459217000	cny
CY2023	us-gaap	Gross Profit GrossProfit	2689883000	cny
CY2023	us-gaap	Gross Profit GrossProfit	370952000	usd
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1694941000	cny
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2254459000	cny
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2408464000	cny
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	332142000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	116265000	cny
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	273484000	cny
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	219781000	cny
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	30309000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	100341000	cny
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	166650000	cny
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	175246000	cny
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	24168000	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	1911547000	cny
CY2022	us-gaap	Operating Expenses OperatingExpenses	2694593000	cny
CY2023	us-gaap	Operating Expenses OperatingExpenses	2803491000	cny
CY2023	us-gaap	Operating Expenses OperatingExpenses	386619000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-330534000	cny
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-235376000	cny
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-113608000	cny
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-15667000	usd
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	441000	cny
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	387000	cny
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	5328000	cny
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	735000	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	15093000	cny
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	19913000	cny
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	21313000	cny
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2939000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-315000000	cny
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-215076000	cny
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-86967000	cny
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11993000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1037000	cny
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	18350000	cny
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	21685000	cny
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2990000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-316037000	cny
CY2022	us-gaap	Profit Loss ProfitLoss	-233426000	cny
CY2023	us-gaap	Profit Loss ProfitLoss	-108652000	cny
CY2023	us-gaap	Profit Loss ProfitLoss	-14983000	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-115000	cny
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-16000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-316037000	cny
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-233426000	cny
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-108537000	cny
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-14967000	usd
CY2021	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	17480000	cny
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	22655000	cny
CY2021	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	197436000	cny
CY2022	us-gaap	Other Preferred Stock Dividends And Adjustments OtherPreferredStockDividendsAndAdjustments	2987000	cny
CY2023	us-gaap	Other Preferred Stock Dividends And Adjustments OtherPreferredStockDividendsAndAdjustments	22379000	cny
CY2023	us-gaap	Other Preferred Stock Dividends And Adjustments OtherPreferredStockDividendsAndAdjustments	3086000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-530953000	cny
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-259068000	cny
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-130916000	cny
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-18053000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-316037000	cny
CY2022	us-gaap	Profit Loss ProfitLoss	-233426000	cny
CY2023	us-gaap	Profit Loss ProfitLoss	-108652000	cny
CY2023	us-gaap	Profit Loss ProfitLoss	-14983000	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	1839000	cny
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	20343000	cny
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	2805000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1839000	cny
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	20343000	cny
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	2805000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-316037000	cny
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-231587000	cny
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-88309000	cny
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-12178000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-115000	cny
CY2023	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-16000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-316037000	cny
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-231587000	cny
CY2022Q2	us-gaap	Prepaid Taxes PrepaidTaxes	690000	cny
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-88194000	cny
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-12162000	usd
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-12.89
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.26
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.26
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-12.89
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-5.26
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.26
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.17
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41206648	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49270950	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	103948398	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	103948398	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41206648	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	49270950	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	103948398	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	103948398	shares
CY2020Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-28258000	cny
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	94028000	cny
CY2021	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	5638000	cny
CY2021	qsg	Stock Issued Duringvalue Distribution To Parent Company StockIssuedDuringvalueDistributionToParentCompany	23601000	cny
CY2021	us-gaap	Profit Loss ProfitLoss	-316037000	cny
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-279506000	cny
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-279506000	cny
CY2022	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	-661173000	cny
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	291429000	cny
CY2022	qsg	Parent Companys Contribution ParentCompanysContribution	94978000	shares
CY2022	qsg	Dividend To Parent Company Upon Disposal Of A Subsidiary To Shareholders DividendToParentCompanyUponDisposalOfASubsidiaryToShareholders	-500000	cny
CY2022	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	2987000	cny
CY2022	us-gaap	Profit Loss ProfitLoss	-233426000	cny
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	1839000	cny
CY2022	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	10365000	cny
CY2022	qsg	Stock Issued During Value Deemed Dividends To Parent Company In Connection With The Sharebased Awards To Employees StockIssuedDuringValueDeemedDividendsToParentCompanyInConnectionWithTheSharebasedAwardsToEmployees	-10365000	cny
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-789346000	cny
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-789346000	cny
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	235462000	cny
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	9984000	cny
CY2023	qsg	Automatic Conversion Of Preferred Shares Into Ordinary Shares Upon Ip Oin Dollars AutomaticConversionOfPreferredSharesIntoOrdinarySharesUponIPOinDollars	686539000	cny
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	191632000	cny
CY2023	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	22379000	cny
CY2023	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	2250000	cny
CY2023	us-gaap	Profit Loss ProfitLoss	-108652000	cny
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	20343000	cny
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	225833000	cny
CY2021	us-gaap	Profit Loss ProfitLoss	-316037000	cny
CY2022	us-gaap	Profit Loss ProfitLoss	-233426000	cny
CY2023	us-gaap	Profit Loss ProfitLoss	-108652000	cny
CY2023	us-gaap	Profit Loss ProfitLoss	-14983000	usd
CY2021	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	629000	cny
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	3000	cny
CY2023	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	40000	cny
CY2023	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	6000	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	442000	cny
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-239000	cny
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-46000	cny
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-6000	usd
CY2021	us-gaap	Depreciation Depreciation	1397000	cny
CY2022	us-gaap	Depreciation Depreciation	4016000	cny
CY2023	us-gaap	Depreciation Depreciation	3714000	cny
CY2023	us-gaap	Depreciation Depreciation	512000	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6025000	cny
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6579000	cny
CY2022	qsg	Loss On Disposal Of Property Equipment And Intangible Assets LossOnDisposalOfPropertyEquipmentAndIntangibleAssets	-124000	cny
CY2021	us-gaap	Gain On Sale Of Investments GainOnSaleOfInvestments	1771000	cny
CY2022	us-gaap	Gain On Sale Of Investments GainOnSaleOfInvestments	4891000	cny
CY2023	us-gaap	Gain On Sale Of Investments GainOnSaleOfInvestments	9195000	cny
CY2023	us-gaap	Gain On Sale Of Investments GainOnSaleOfInvestments	1268000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	101830000	cny
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	291429000	cny
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	191632000	cny
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	26428000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1266000	cny
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1446000	cny
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2084000	cny
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-287000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	98885000	cny
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-55351000	cny
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	10268000	cny
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1416000	usd
CY2022	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	23202000	cny
CY2023	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	6108000	cny
CY2023	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	842000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	96774000	cny
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4480000	cny
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	21121000	cny
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2913000	usd
CY2021	qsg	Increase Decrease Operating Lease Rightofuse Assets IncreaseDecreaseOperatingLeaseRightofuseAssets	8924000	cny
CY2022	qsg	Increase Decrease Operating Lease Rightofuse Assets IncreaseDecreaseOperatingLeaseRightofuseAssets	14573000	cny
CY2023	qsg	Increase Decrease Operating Lease Rightofuse Assets IncreaseDecreaseOperatingLeaseRightofuseAssets	60092000	cny
CY2023	qsg	Increase Decrease Operating Lease Rightofuse Assets IncreaseDecreaseOperatingLeaseRightofuseAssets	8287000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	62137000	cny
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2633000	cny
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	16916000	cny
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2333000	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	54525000	cny
CY2022	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	61046000	cny
CY2023	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	62370000	cny
CY2023	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	8601000	usd
CY2021	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	2303000	cny
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	5035000	cny
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	1496000	cny
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	206000	usd
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	253573000	cny
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	99511000	cny
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	123622000	cny
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	17048000	usd
CY2021	qsg	Increase Decrease From Advance From Customers IncreaseDecreaseFromAdvanceFromCustomers	118992000	cny
CY2022	qsg	Increase Decrease From Advance From Customers IncreaseDecreaseFromAdvanceFromCustomers	17888000	cny
CY2023	qsg	Increase Decrease From Advance From Customers IncreaseDecreaseFromAdvanceFromCustomers	-6692000	cny
CY2023	qsg	Increase Decrease From Advance From Customers IncreaseDecreaseFromAdvanceFromCustomers	-923000	usd
CY2021	qsg	Operating Lease Liabilities Current Portion OperatingLeaseLiabilitiesCurrentPortion	6647000	cny
CY2022	qsg	Operating Lease Liabilities Current Portion OperatingLeaseLiabilitiesCurrentPortion	9203000	cny
CY2023	qsg	Operating Lease Liabilities Current Portion OperatingLeaseLiabilitiesCurrentPortion	24761000	cny
CY2023	qsg	Operating Lease Liabilities Current Portion OperatingLeaseLiabilitiesCurrentPortion	3415000	usd
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	1942000	cny
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	4624000	cny
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	46274000	cny
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	6381000	usd
CY2021	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	6102000	cny
CY2022	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	2543000	cny
CY2023	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	10866000	cny
CY2023	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	1500000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	79425000	cny
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	272636000	cny
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	235621000	cny
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	32493000	usd
CY2021	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	434600000	cny
CY2022	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	976700000	cny
CY2023	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	2891452000	cny
CY2023	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	398749000	usd
CY2021	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	405600000	cny
CY2022	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	873700000	cny
CY2023	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	2863828000	cny
CY2023	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	394940000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5822000	cny
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4560000	cny
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5756000	cny
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	794000	usd
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	29804000	cny
CY2021	us-gaap	Proceeds From Lease Payment Sales Type And Direct Financing Leases Investing Activity ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity	1771000	cny
CY2022	us-gaap	Proceeds From Lease Payment Sales Type And Direct Financing Leases Investing Activity ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity	4891000	cny
CY2023	us-gaap	Proceeds From Lease Payment Sales Type And Direct Financing Leases Investing Activity ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity	9195000	cny
CY2023	us-gaap	Proceeds From Lease Payment Sales Type And Direct Financing Leases Investing Activity ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity	1268000	usd
CY2022	us-gaap	Proceeds From Divestiture Of Interest In Subsidiaries And Affiliates ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates	14126000	cny
CY2023	us-gaap	Proceeds From Divestiture Of Interest In Subsidiaries And Affiliates ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates	2000000	cny
CY2023	us-gaap	Proceeds From Divestiture Of Interest In Subsidiaries And Affiliates ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates	276000	usd
CY2021	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	2448000	cny
CY2022	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	129427000	cny
CY2023	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	2243000	cny
CY2023	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	309000	usd
CY2021	us-gaap	Proceeds From Collection Of Loans Receivable ProceedsFromCollectionOfLoansReceivable	2950000	cny
CY2022	us-gaap	Proceeds From Collection Of Loans Receivable ProceedsFromCollectionOfLoansReceivable	109389000	cny
CY2023	us-gaap	Proceeds From Collection Of Loans Receivable ProceedsFromCollectionOfLoansReceivable	24629000	cny
CY2023	us-gaap	Proceeds From Collection Of Loans Receivable ProceedsFromCollectionOfLoansReceivable	3396000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-62353000	cny
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-108581000	cny
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	201000	cny
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	28000	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	15917000	cny
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	15917000	cny
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	15917000	cny
CY2023	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	235462000	cny
CY2023	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	32472000	usd
CY2023	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	9984000	cny
CY2023	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	1377000	usd
CY2023	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	2250000	cny
CY2023	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	310000	usd
CY2021	qsg	Increase Decrease In Distribution To Contribution From Predecessors IncreaseDecreaseInDistributionToContributionFromPredecessors	37041000	cny
CY2022	qsg	Increase Decrease In Distribution To Contribution From Predecessors IncreaseDecreaseInDistributionToContributionFromPredecessors	-94978000	cny
CY2021	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	52711000	cny
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	122833000	cny
CY2021	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	36763000	cny
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	146182000	cny
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-21093000	cny
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	71629000	cny
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	247696000	cny
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	34159000	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5642000	cny
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14336000	cny
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1977000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4021000	cny
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	241326000	cny
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	497854000	cny
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	68657000	usd
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	29122000	cny
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	25101000	cny
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	266427000	cny
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	36742000	usd
CY2020Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	29095000	cny
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	25101000	cny
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	266427000	cny
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	36742000	usd
CY2020Q2	us-gaap	Restricted Cash RestrictedCash	27000	cny
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	25101000	cny
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	266427000	cny
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	764281000	cny
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	105399000	usd
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	25101000	cny
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	266427000	cny
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	764281000	cny
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	105399000	usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	14761000	cny
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	22273000	cny
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	3072000	usd
CY2022	qsg	Consideration Receivable As A Result Of Disposal Of Subsidiaries ConsiderationReceivableAsAResultOfDisposalOfSubsidiaries	2000000	cny
CY2023	us-gaap	Noncash Or Part Noncash Acquisition Other Assets Acquired1 NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1	198000	cny
CY2023	us-gaap	Noncash Or Part Noncash Acquisition Other Assets Acquired1 NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1	27000	usd
CY2022	qsg	Accretion Of The Companys Preferred Shares AccretionOfTheCompanysPreferredShares	2987000	cny
CY2023	qsg	Accretion Of The Companys Preferred Shares AccretionOfTheCompanysPreferredShares	22379000	cny
CY2023	qsg	Accretion Of The Companys Preferred Shares AccretionOfTheCompanysPreferredShares	3086000	usd
CY2023	qsg	Beneficial Interest Rate BeneficialInterestRate	1	pure
CY2023Q2	us-gaap	Prepaid Taxes PrepaidTaxes	360000	cny
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	615674000	cny
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	110640000	cny
CY2023	qsg	Exclusive Consultancy And Service Agreements Term ExclusiveConsultancyAndServiceAgreementsTerm	P10Y
CY2023	qsg	Exclusive Consultancy And Service Agreements Extended Term ExclusiveConsultancyAndServiceAgreementsExtendedTerm	P10Y
CY2023	us-gaap	Statutory Accounting Practices Statutory Net Income Amount StatutoryAccountingPracticesStatutoryNetIncomeAmount	1568000	cny
CY2023Q2	us-gaap	Reorganization Value Cash In Excess Of Normal Operating Needs ReorganizationValueCashInExcessOfNormalOperatingNeeds	155960000	cny
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left"><b><i>(c)</i></b></td><td style="text-align: justify"><b><i>Use of estimates</i></b></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0pt">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires the Group to make estimates and assumptions that affect the reported amounts of assets and liabilities and related disclosure of contingent assets and liabilities at the balance sheet date, and the reported revenues and expense during the reporting period and disclosed in the consolidated financial statements and accompanying notes.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0pt">Significant accounting estimates reflected in the Group’s consolidated financial statements include revenue recognition based on the estimated average learning period of the learners, standalone selling price of each distinct performance obligation in revenue recognition, variable consideration in revenue recognition, provision of credit losses of receivables, fair value of short-term investments, incremental borrowing rate used in initial measurement of leases, depreciation and amortization of long-lived assets, impairment of long-lived assets, the valuation allowance of deferred tax assets, as well as the valuation and recognition of share-based compensation arrangements. Actual results could differ from those estimates and such differences may be material to the consolidated financial statements.</p>
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	1937000	cny
CY2023Q2	us-gaap	Accounts Receivable Net AccountsReceivableNet	12251000	cny
CY2022Q2	qsg	Receivables From Third Party Payment ReceivablesFromThirdPartyPayment	9456000	cny
CY2023Q2	qsg	Receivables From Third Party Payment ReceivablesFromThirdPartyPayment	22533000	cny
CY2023	us-gaap	Description Of Difference Between Reported Amount And Reporting Currency Denominated Amount DescriptionOfDifferenceBetweenReportedAmountAndReportingCurrencyDenominatedAmount	US$1.00=RMB7.2513
CY2023	us-gaap	Property Plant And Equipment Basis Of Valuation PropertyPlantAndEquipmentBasisOfValuation	Shorter of the lease term or estimated economic life
CY2023Q2	us-gaap	Property Plant And Equipment Useful Life PropertyPlantAndEquipmentUsefulLife	P3Y
CY2021Q2	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	-446000	cny
CY2020Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	40514000	cny
CY2021Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	267729000	cny
CY2022Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	384729000	usd
CY2023	qsg	Contract Liabilities Balance ContractLiabilitiesBalance	517220000	cny
CY2023Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	517213000	cny
CY2022Q2	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	-13000	cny
CY2022	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	433000	cny
CY2023	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	-46000	cny
CY2021	us-gaap	Revenues Revenues	1759940000	cny
CY2022	us-gaap	Revenues Revenues	2867974000	cny
CY2023	us-gaap	Revenues Revenues	3081381000	cny
CY2021	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	1306501000	cny
CY2022	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	1590886000	cny
CY2023	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	1743473000	cny
CY2022Q2	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	-13000	cny
CY2023Q2	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	-59000	cny
CY2022Q2	qsg	Prepaid Prepayments For Promotion Fees PrepaidPrepaymentsForPromotionFees	86686000	cny
CY2023Q2	qsg	Prepaid Prepayments For Promotion Fees PrepaidPrepaymentsForPromotionFees	65832000	cny
CY2022Q2	qsg	Prepaid Other Service Fees PrepaidOtherServiceFees	13726000	cny
CY2021	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	39449000	cny
CY2022	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	111698000	cny
CY2023	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	124922000	cny
CY2022Q2	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	30974000	cny
CY2023Q2	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	51645000	cny
CY2023Q2	qsg	Value Added Tax Rate ValueAddedTaxRate	0.06	pure
CY2023Q2	qsg	Prepaid Other Service Fees PrepaidOtherServiceFees	25281000	cny
CY2022Q2	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	346667000	cny
CY2022	qsg	Cash Cash Equivalents And Short Term Investmentspercentage CashCashEquivalentsAndShortTermInvestmentspercentage	0.8687	pure
CY2023Q2	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	625698000	cny
CY2023	qsg	Cash Cash Equivalents And Short Term Investmentspercentage CashCashEquivalentsAndShortTermInvestmentspercentage	0.6724	pure
CY2022	qsg	Gross Accounts Receivable For Marketing Services GrossAccountsReceivableForMarketingServices	23202000	cny
CY2023	qsg	Gross Accounts Receivable For Marketing Services GrossAccountsReceivableForMarketingServices	29116000	cny
CY2022	qsg	Accounts Receivables Percentage AccountsReceivablesPercentage	0.922	pure
CY2023	qsg	Accounts Receivables Percentage AccountsReceivablesPercentage	0.704	pure
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	13000	cny
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	59000	cny
CY2023Q2	qsg	Receivables From Live Ecommerce Business Platforms ReceivablesFromLiveEcommerceBusinessPlatforms	1760000	cny
CY2022Q2	qsg	Staff Advance Current StaffAdvanceCurrent	192000	cny
CY2023Q2	qsg	Staff Advance Current StaffAdvanceCurrent	575000	cny
CY2022Q2	qsg	Deposits Current DepositsCurrent	4791000	cny
CY2023Q2	qsg	Deposits Current DepositsCurrent	3500000	cny
CY2023Q2	us-gaap	Interest Receivable InterestReceivable	3297000	cny
CY2022Q2	us-gaap	Other Assets Current OtherAssetsCurrent	19000	cny
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	115560000	cny
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	136681000	cny
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	10664000	cny
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	11774000	cny
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5495000	cny
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4365000	cny
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5169000	cny
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7409000	cny
CY2021	us-gaap	Depreciation Depreciation	1397000	cny
CY2022	us-gaap	Depreciation Depreciation	4016000	cny
CY2023	us-gaap	Depreciation Depreciation	3714000	cny
CY2023Q2	us-gaap	Short Term Investments ShortTermInvestments	166303000	cny
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.016	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.118	pure
CY2021	qsg	Permanent Differences PermanentDifferences	-0.08	pure
CY2022Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	78245000	cny
CY2023Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	128097000	cny
CY2022Q2	qsg	Other Accrued Expense Current OtherAccruedExpenseCurrent	16807000	cny
CY2023Q2	qsg	Other Accrued Expense Current OtherAccruedExpenseCurrent	23501000	cny
CY2022Q2	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	12594000	cny
CY2023Q2	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	18640000	cny
CY2022Q2	qsg	Refund Liability Current RefundLiabilityCurrent	615000	cny
CY2023Q2	qsg	Refund Liability Current RefundLiabilityCurrent	513000	cny
CY2022Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	331000	cny
CY2023Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	409000	cny
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	108592000	cny
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	171160000	cny
CY2023Q2	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P12M
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	23917000	cny
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	84009000	cny
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	16331000	cny
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	41092000	cny
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6566000	cny
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	52840000	cny
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	10036000	cny
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	21943000	cny
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	37484000	cny
CY2021	us-gaap	Short Term Lease Cost ShortTermLeaseCost	1415000	cny
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	2730000	cny
CY2023	us-gaap	Short Term Lease Cost ShortTermLeaseCost	2272000	cny
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	11280000	cny
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	20854000	cny
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	25151000	cny
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	22231000	cny
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	28091000	cny
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	95206000	cny
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y3M3D
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y2M19D
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0475	pure
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0475	pure
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	44599000	cny
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	41659000	cny
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	13086000	cny
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	99344000	cny
CY2023Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	5412000	cny
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	93932000	cny
CY2022Q2	us-gaap	Short Term Investments ShortTermInvestments	132632000	cny
CY2023	qsg	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset S Investment Made FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSInvestmentMade	87885000	cny
CY2023	qsg	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Redemption FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetRedemption	36028000	cny
CY2023	qsg	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLoss	401000	cny
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease	5965000	cny
CY2023Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	58223000	cny
CY2018Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.165	pure
CY2018Q2	us-gaap	Development Profits Nonoperating DevelopmentProfitsNonoperating	2000000	hkd
CY2018Q2	qsg	Percentage Of Assessable Profits PercentageOfAssessableProfits	0.165	pure
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.15	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.15	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Deductions Dividends EffectiveIncomeTaxRateReconciliationDeductionsDividends	0.25	pure
CY2023	qsg	Dividend Income Securitie Operating Tax Advantaged DividendIncomeSecuritieOperatingTaxAdvantaged	0.10	pure
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	2303000	cny
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	19796000	cny
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	23769000	cny
CY2021	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-1266000	cny
CY2022	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-1446000	cny
CY2023	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-2084000	cny
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1037000	cny
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	18350000	cny
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	21685000	cny
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25	pure
CY2022	qsg	Permanent Differences PermanentDifferences	-0.246	pure
CY2023	qsg	Permanent Differences PermanentDifferences	-0.355	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.189	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.088	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.262	pure
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.003	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.084	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.249	pure
CY2021	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	4952000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.12
CY2021	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.12
CY2022Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	380000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	790000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	18611000	usd
CY2022Q2	qsg	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deductible Temporary Difference Related To Advertising Expenses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeductibleTemporaryDifferenceRelatedToAdvertisingExpenses	35384000	usd
CY2023Q2	qsg	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deductible Temporary Difference Related To Advertising Expenses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeductibleTemporaryDifferenceRelatedToAdvertisingExpenses	44843000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	48642000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	49581000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	84406000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	113825000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	84406000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	94975000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	18850000	usd
CY2023Q2	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	16766000	usd
CY2023Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	16766000	usd
CY2023	qsg	Other Transactions OtherTransactions	11663000	cny
CY2021	qsg	Other Transactions Net OtherTransactionsNet	15093000	cny
CY2022	qsg	Other Transactions Net OtherTransactionsNet	19913000	cny
CY2023Q2	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	259876000	cny
CY2020Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	5693000	cny
CY2021Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	65235000	cny
CY2022Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	84406000	cny
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	59542000	cny
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	19171000	cny
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	10569000	cny
CY2021Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	65235000	cny
CY2022Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	84406000	cny
CY2023Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	94975000	cny
CY2021	qsg	Government Grants GovernmentGrants	3010000	cny
CY2022	qsg	Government Grants GovernmentGrants	69000	cny
CY2023	qsg	Government Grants GovernmentGrants	415000	cny
CY2021	qsg	Fair Value Changes Of Shortterm Investments FairValueChangesOfShorttermInvestments	2400000	cny
CY2022	qsg	Fair Value Changes Of Shortterm Investments FairValueChangesOfShorttermInvestments	4894000	cny
CY2023	qsg	Fair Value Changes Of Shortterm Investments FairValueChangesOfShorttermInvestments	9235000	cny
CY2021	qsg	Other Transactions OtherTransactions	9683000	cny
CY2022	qsg	Other Transactions OtherTransactions	14950000	cny
CY2023	qsg	Other Transactions Net OtherTransactionsNet	21313000	cny
CY2021	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	101830000	cny
CY2022	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	291429000	cny
CY2023	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	191632000	cny
CY2018Q2	us-gaap	Employee Stock Ownership Plan Esop Number Of Suspense Shares EmployeeStockOwnershipPlanESOPNumberOfSuspenseShares	22317118	shares
CY2022	qsg	Share Based Compensation Options Vested Rate ShareBasedCompensationOptionsVestedRate	0.25	pure
CY2021Q2	us-gaap	Employee Stock Ownership Plan Esop Number Of Suspense Shares EmployeeStockOwnershipPlanESOPNumberOfSuspenseShares	21717118	shares
CY2021Q2	us-gaap	Option Indexed To Issuers Equity Settlement Alternatives Shares At Fair Value OptionIndexedToIssuersEquitySettlementAlternativesSharesAtFairValue	14358812	shares
CY2021Q2	qsg	Fair Value Of Awards FairValueOfAwards	253673000	cny
CY2021Q2	qsg	Vested Amount VestedAmount	35617000	cny
	qsg	Share Based Compensation Options Vested Rate ShareBasedCompensationOptionsVestedRate	0.25	pure
CY2022Q2	us-gaap	Employee Stock Ownership Plan Esop Number Of Allocated Shares EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares	21717118	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	16523627	shares
CY2022Q2	qsg	Vested Amount VestedAmount	117520000	cny
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	70000	shares
CY2022Q3	qsg	Share Based Compensation Options Vested Rate ShareBasedCompensationOptionsVestedRate	0.25	pure
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	3305000	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	7190000	shares
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	17224000	cny
CY2023Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	7460000	cny
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	500000	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	10984915	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	2298000	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	3375000	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Other Share Increase Decrease In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOtherShareIncreaseDecreaseInPeriodWeightedAverageExercisePrice	0.78
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Other Share Increase Decrease In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOtherShareIncreaseDecreaseInPeriodWeightedAverageExercisePrice	2.56
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Other Share Increase Decrease In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOtherShareIncreaseDecreaseInPeriodWeightedAverageExercisePrice	3.77
CY2022Q2	qsg	Granted Shares GrantedShares	510500	shares
CY2022Q2	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	510500	shares
CY2023Q2	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	274500	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.66
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.61
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	121750	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	141750	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	0.56
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	0.55
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P8Y5M12D
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P8Y11M1D
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	10306000	cny
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	4364000	cny
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	2539000	cny
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	2319000	cny
CY2022	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome	10365000	cny
CY2021Q2	us-gaap	Deferred Compensation Arrangement With Individual Allocated Share Based Compensation Expense DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense	164630000	cny
CY2022Q2	us-gaap	Deferred Compensation Arrangement With Individual Allocated Share Based Compensation Expense DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense	227395000	cny
CY2023Q2	us-gaap	Deferred Compensation Arrangement With Individual Allocated Share Based Compensation Expense DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense	119847000	cny
CY2021Q2	qsg	Recognized Weighted Average Period RecognizedWeightedAveragePeriod	P2Y8M12D
CY2022Q2	qsg	Recognized Weighted Average Period RecognizedWeightedAveragePeriod	P2Y4M20D
CY2023Q2	qsg	Recognized Weighted Average Period RecognizedWeightedAveragePeriod	P1Y5M15D
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P10Y
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P10Y
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P10Y
CY2017Q2	us-gaap	Restricted Stock Shares Issued Net Of Shares For Tax Withholdings RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings	63000200	shares
CY2018Q2	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	20353910	shares
CY2018Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.0001
CY2018Q2	us-gaap	Restricted Stock Shares Issued Net Of Shares For Tax Withholdings RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings	13036792	shares
CY2018Q2	qsg	Vested Share Percentage VestedSharePercentage	0.25	pure
CY2020Q3	qsg	Repurchased Restricted Shares RepurchasedRestrictedShares	1640444	shares
CY2020Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	1.18
CY2020Q3	us-gaap	Option Contract Indexed To Equity Settlement Share Fair Value Per Share OptionContractIndexedToEquitySettlementShareFairValuePerShare	0.49
CY2020Q3	qsg	Vested Share VestedShare	600000	shares
CY2020Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.85
CY2023	qsg	Restriction Of Ordinary Shares Held By The Founder Description RestrictionOfOrdinarySharesHeldByTheFounderDescription	In November 2020, these options were approved by the board to be exercised as 600,000 Class A ordinary shares, and the Founder agreed with Witty network to classify 150,000, out of the 600,000 Class A ordinary shares as additional Restricted Shares, with 50% of these shares vested on August 13, 2021 and 2022 respectively. In addition, the Founder further agreed with Witty network that 410,111 Class B ordinary shares of the previously granted Restricted Shares were vested immediately, while the remaining 13,510,660 Class B ordinary shares, being the unvested Restricted Shares, were also modified with 50% vested on August 13, 2021 and 2022 respectively. Such modification did not have any material impact on the fair value of these share options.
CY2022Q2	qsg	Unvested Restricted Shares UnvestedRestrictedShares	75000	shares
CY2022Q3	qsg	Vested Restricted Shares VestedRestrictedShares	6755330	shares
CY2020Q3	us-gaap	Shares Issued SharesIssued	13920770	shares
CY2020Q3	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	1640444	shares
CY2020Q3	us-gaap	Shares Issued SharesIssued	54042638	shares
CY2020Q3	us-gaap	Restricted Stock Shares Issued Net Of Shares For Tax Withholdings RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings	13920770	shares
CY2023Q2	us-gaap	Shares Issued SharesIssued	150000	shares
CY2022Q1	qsg	Share Capital ShareCapital	50000000	usd
CY2022Q1	us-gaap	Shares Issued SharesIssued	500000000	shares
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Shares Issued SharesIssued	4183589	shares
CY2022Q2	us-gaap	Restricted Stock Shares Issued Net Of Shares For Tax Withholdings RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings	75000	shares
CY2023Q1	us-gaap	Capital Units Authorized CapitalUnitsAuthorized	700000000	shares
CY2023Q1	us-gaap	Shares Issued SharesIssued	200000000	shares
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	37200000	usd
CY2023Q1	qsg	Option To Purchase Additional OptionToPurchaseAdditional	127396	shares
CY2023Q1	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	1500000	usd
CY2023	qsg	Deemed Preferred Share Issue Price Percentage DeemedPreferredShareIssuePricePercentage	1	pure
CY2023Q2	qsg	Preferred Stock Voting Power Outstanding Percentage PreferredStockVotingPowerOutstandingPercentage	0.50	pure
CY2022	qsg	Stock And Warrants Issued During Period Shares Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodSharesPreferredStockAndWarrants	100843631	shares
CY2022	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	661173000	cny
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	2987000	cny
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	100843631	shares
CY2022Q2	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	664160000	cny
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	100843631	shares
CY2022Q2	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	664160000	cny
CY2023	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	22379000	cny
CY2023	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	100843631	shares
CY2023	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	686539000	cny
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	54642638	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	47812308	shares
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	100843631	shares
CY2021	us-gaap	Profit Loss ProfitLoss	-316037000	cny
CY2022	us-gaap	Profit Loss ProfitLoss	-233426000	cny
CY2023	us-gaap	Profit Loss ProfitLoss	-108652000	cny
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-115000	cny
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-316037000	cny
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-233426000	cny
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-108537000	cny
CY2021	us-gaap	Temporary Equity Other Changes TemporaryEquityOtherChanges	17480000	cny
CY2022	us-gaap	Temporary Equity Other Changes TemporaryEquityOtherChanges	22655000	cny
CY2021	qsg	Allocation Of Deemed Dividends Due To Extinguishment Of Predecessors Preferred Shares AllocationOfDeemedDividendsDueToExtinguishmentOfPredecessorsPreferredShares	197436000	cny
CY2022	qsg	Accretion Of The Companys Preferred Share AccretionOfTheCompanysPreferredShare	2987000	cny
CY2023	qsg	Accretion Of The Companys Preferred Share AccretionOfTheCompanysPreferredShare	22379000	cny
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-530953000	cny
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-259068000	cny
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-130916000	cny
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41206648	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49270950	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	103948398	shares
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-12.89
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.26
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.26
CY2021	us-gaap	Preferred Stock Redemption Premium PreferredStockRedemptionPremium	17480000	cny
CY2022	us-gaap	Preferred Stock Redemption Premium PreferredStockRedemptionPremium	22655000	cny
CY2021	us-gaap	Dividends Dividends	197436000	cny
CY2021	qsg	Vested Shares VestedShares	232930	shares
CY2022	qsg	Vested Shares VestedShares	2276065	shares
CY2023	qsg	Vested Shares VestedShares	3318369	shares
CY2021	us-gaap	Other General Expense OtherGeneralExpense	615674000	cny
CY2022	us-gaap	Other General Expense OtherGeneralExpense	110640000	cny
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		cny
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
CY2022	qsg	Transactions Recorded In Revenue TransactionsRecordedInRevenue	44710000	cny
CY2023	qsg	Transactions Recorded In Revenue TransactionsRecordedInRevenue	147921000	cny
CY2021	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	36763000	cny
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	146182000	cny
CY2021	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	52711000	cny
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	122833000	cny
CY2021	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	2448000	cny
CY2022	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	129427000	cny
CY2023	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	2243000	cny
CY2021	us-gaap	Proceeds From Collection Of Loans Receivable ProceedsFromCollectionOfLoansReceivable	2950000	cny
CY2022	us-gaap	Proceeds From Collection Of Loans Receivable ProceedsFromCollectionOfLoansReceivable	109389000	cny
CY2023	us-gaap	Proceeds From Collection Of Loans Receivable ProceedsFromCollectionOfLoansReceivable	24629000	cny
CY2022	qsg	Disposal Of Subsidiaries To Related Parties DisposalOfSubsidiariesToRelatedParties	20000000	cny
CY2023	qsg	Disposal Of Subsidiaries To Related Parties DisposalOfSubsidiariesToRelatedParties	2000000	cny
CY2022Q2	us-gaap	Other Receivables OtherReceivables	47394000	cny
CY2023Q2	us-gaap	Other Receivables OtherReceivables	29116000	cny
CY2022	qsg	Cash Consideration For Disposal CashConsiderationForDisposal	20000000	cny
CY2023	qsg	Cash Consideration For Disposal CashConsiderationForDisposal	2000000	cny
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents		cny
CY2022Q1	us-gaap	Discontinued Operation Equity Method Investment Retained After Disposal Ownership Interest Prior To Disposal DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestPriorToDisposal	1	pure
CY2022Q1	us-gaap	Discontinued Operation Amount Of Adjustment To Prior Period Gain Loss On Disposal Net Of Tax DiscontinuedOperationAmountOfAdjustmentToPriorPeriodGainLossOnDisposalNetOfTax	50000000	cny
CY2022Q1	us-gaap	Discontinued Operation Amount Of Adjustment To Prior Period Gain Loss On Disposal Before Income Tax DiscontinuedOperationAmountOfAdjustmentToPriorPeriodGainLossOnDisposalBeforeIncomeTax	28000000	cny
CY2022Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	500000	cny
CY2022Q1	us-gaap	Income Loss From Individually Significant Component Disposed Of Or Held For Sale Excluding Discontinued Operations Attributable To Noncontrolling Interest Before Income Tax IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsAttributableToNoncontrollingInterestBeforeIncomeTax	22000000	cny
CY2023Q2	qsg	Future Minimum Commitment Office Rentals Year One FutureMinimumCommitmentOfficeRentalsYearOne	786000	cny
CY2023Q2	qsg	Future Minimum Commitment Office Rentals Year One To Five FutureMinimumCommitmentOfficeRentalsYearOneToFive	786000	cny
CY2023Q2	qsg	Future Minimum Commitment Office Rentals FutureMinimumCommitmentOfficeRentals	1572000	cny
CY2023Q2	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	20000000	usd
CY2023Q2	qsg	Annual Appropriations AnnualAppropriations	0.10	pure
CY2023Q2	qsg	Restricted Portion RestrictedPortion	74022000	cny
CY2021Q2	us-gaap	Restricted Cash RestrictedCash		cny
CY2022Q2	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome		cny
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		cny
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		cny
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q2	us-gaap	Members Equity Attributable To Noncontrolling Interest MembersEquityAttributableToNoncontrollingInterest		cny
CY2023Q2	us-gaap	Members Equity Attributable To Noncontrolling Interest MembersEquityAttributableToNoncontrollingInterest		usd
CY2022Q2	us-gaap	Minority Interest MinorityInterest		cny
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		cny
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		cny
CY2023	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment		cny
CY2023	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment		usd
CY2022	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact		cny
CY2023	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact		cny
CY2023	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact		usd
CY2021	us-gaap	Other Preferred Stock Dividends And Adjustments OtherPreferredStockDividendsAndAdjustments		cny
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax		cny
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax		cny
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest		cny
CY2022	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest		cny
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets		cny
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets		usd
CY2021	qsg	Loss On Disposal Of Property Equipment And Intangible Assets LossOnDisposalOfPropertyEquipmentAndIntangibleAssets		cny
CY2023	qsg	Loss On Disposal Of Property Equipment And Intangible Assets LossOnDisposalOfPropertyEquipmentAndIntangibleAssets		cny
CY2023	qsg	Loss On Disposal Of Property Equipment And Intangible Assets LossOnDisposalOfPropertyEquipmentAndIntangibleAssets		usd
CY2021	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent		cny
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		cny
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		cny
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
CY2021	us-gaap	Proceeds From Divestiture Of Interest In Subsidiaries And Affiliates ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates		cny
CY2021	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		cny
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		cny
CY2021	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement		cny
CY2022	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement		cny
CY2021	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders		cny
CY2022	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders		cny
CY2023	qsg	Increase Decrease In Distribution To Contribution From Predecessors IncreaseDecreaseInDistributionToContributionFromPredecessors		cny
CY2023	qsg	Increase Decrease In Distribution To Contribution From Predecessors IncreaseDecreaseInDistributionToContributionFromPredecessors		usd
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		cny
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
CY2022Q2	us-gaap	Restricted Cash RestrictedCash		cny
CY2022Q2	us-gaap	Restricted Cash RestrictedCash		usd
CY2021Q2	us-gaap	Restricted Cash RestrictedCash		cny
CY2022Q2	us-gaap	Restricted Cash RestrictedCash		cny
CY2023Q2	us-gaap	Restricted Cash RestrictedCash		cny
CY2023Q2	us-gaap	Restricted Cash RestrictedCash		usd
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid		cny
CY2021	qsg	Consideration Receivable As A Result Of Disposal Of Subsidiaries ConsiderationReceivableAsAResultOfDisposalOfSubsidiaries		cny
CY2023	qsg	Consideration Receivable As A Result Of Disposal Of Subsidiaries ConsiderationReceivableAsAResultOfDisposalOfSubsidiaries		cny
CY2023	qsg	Consideration Receivable As A Result Of Disposal Of Subsidiaries ConsiderationReceivableAsAResultOfDisposalOfSubsidiaries		usd
CY2021	us-gaap	Noncash Or Part Noncash Acquisition Other Assets Acquired1 NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1		cny
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Other Assets Acquired1 NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1		cny
CY2021	qsg	Accretion Of The Companys Preferred Shares AccretionOfTheCompanysPreferredShares		cny
CY2022Q2	us-gaap	Other Additional Capital OtherAdditionalCapital		cny
CY2023Q2	us-gaap	Other Additional Capital OtherAdditionalCapital		cny
CY2022	us-gaap	Statutory Accounting Practices Statutory Net Income Amount StatutoryAccountingPracticesStatutoryNetIncomeAmount		cny
CY2022	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs		cny
CY2023	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs		cny
CY2022Q2	qsg	Prepayments For Products Procurement PrepaymentsForProductsProcurement		cny
CY2022Q2	qsg	Receivables From Live Ecommerce Business Platforms ReceivablesFromLiveEcommerceBusinessPlatforms		cny
CY2022Q2	us-gaap	Interest Receivable InterestReceivable		cny
CY2023Q2	us-gaap	Other Assets Current OtherAssetsCurrent		cny
CY2022Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue		cny
CY2022	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes		usd
CY2023	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes		usd
CY2022	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare
CY2023	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare
CY2022	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare
CY2023	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare
CY2022Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther		usd
CY2022Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q2	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther		usd
CY2022Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities		usd
CY2023	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome		usd
CY2021Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2021Q2	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding		cny
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2023Q2	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding		cny
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		cny
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		cny
CY2023	us-gaap	Temporary Equity Other Changes TemporaryEquityOtherChanges		cny
CY2022	qsg	Allocation Of Deemed Dividends Due To Extinguishment Of Predecessors Preferred Shares AllocationOfDeemedDividendsDueToExtinguishmentOfPredecessorsPreferredShares		cny
CY2023	qsg	Allocation Of Deemed Dividends Due To Extinguishment Of Predecessors Preferred Shares AllocationOfDeemedDividendsDueToExtinguishmentOfPredecessorsPreferredShares		cny
CY2021	qsg	Accretion Of The Companys Preferred Share AccretionOfTheCompanysPreferredShare		cny
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	103948398	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41206648	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	49270950	shares
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-12.89
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.26
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-5.26
CY2023	us-gaap	Preferred Stock Redemption Premium PreferredStockRedemptionPremium		cny
CY2022	us-gaap	Dividends Dividends		cny
CY2023	us-gaap	Dividends Dividends		cny
CY2021	qsg	Transactions Recorded In Revenue TransactionsRecordedInRevenue		cny
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		cny
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		cny
CY2021	qsg	Disposal Of Subsidiaries To Related Parties DisposalOfSubsidiariesToRelatedParties		cny
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001932770

Files In Submission

Name	View Source	Status
0001013762-23-007052-index-headers.html	Edgar Link	pending
0001013762-23-007052-index.html	Edgar Link	pending
0001013762-23-007052.txt	Edgar Link	pending
0001013762-23-007052-xbrl.zip	Edgar Link	pending
ex15-2_001.jpg	Edgar Link	pending
ex15-2_002.jpg	Edgar Link	pending
ex15-3_001.jpg	Edgar Link	pending
f20f2023ex1-1_quantasing.htm	Edgar Link	pending
f20f2023ex11-2_quantasing.htm	Edgar Link	pending
f20f2023ex12-1_quantasing.htm	Edgar Link	pending
f20f2023ex12-2_quantasing.htm	Edgar Link	pending
f20f2023ex13-1_quantasing.htm	Edgar Link	pending
f20f2023ex13-2_quantasing.htm	Edgar Link	pending
f20f2023ex15-1_quantasing.htm	Edgar Link	pending
f20f2023ex15-2_quantasing.htm	Edgar Link	pending
f20f2023ex15-3_quantasing.htm	Edgar Link	pending
f20f2023ex2-3_quantasing.htm	Edgar Link	pending
f20f2023ex2-5_quantasing.htm	Edgar Link	pending
f20f2023ex8-1_quantasing.htm	Edgar Link	pending
f20f2023_quantasing.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
qsg-20230630.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
qsg-20230630_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
qsg-20230630_def.xml	Edgar Link	unprocessable
qsg-20230630_lab.xml	Edgar Link	unprocessable
f20f2023_quantasing_htm.xml	Edgar Link	completed
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
qsg-20230630_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$QSG
QuantaSing Group Ltd Stock $qsg

2023 Q2 Form 20-F Financial Statement

#000101376223007052 Filed on October 27, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$QSG QuantaSing Group Ltd Stock $qsg

2023 Q2 Form 20-F Financial Statement

#000101376223007052 Filed on October 27, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$QSG
QuantaSing Group Ltd Stock $qsg